Netris Pharma Raises €7.5M; Extends Series A to €24.4M
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Patrick Mehlen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Mehlen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Mehlen Today - Breaking & Trending Today
Netris pancreatic cancer study doses first patient
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials - News - PharmaTimes
Source: pharmatimes.com
NETRIS Pharma Doses First Patient in Pancreatic Cancer Clinical Study with NP137
Lap-NET1 study will evaluate safety and efficacy of anti-netrin-1 antibody NP137 in combination with m_FOLFIRINOX as first-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma March 29th, 2023 LYON, France —NETRIS Pharma, a clinical-stage private biopharmaceutical company developin...
Source: pharmiweb.com
Netris Pharma starts hepatocellular carcinoma study
Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev - News - PharmaTimes
Source: pharmatimes.com
NETRIS Pharma, Orano and CLB partner to develop new radio-conjugates
NETRIS Pharma, Orano and CLB have entered into a scientific collaboration agreement for the development of new antibody radio-conjugates to treat cancer.